Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Pharmacokinetic Dose Guidance of IV Busulfan with Fludarabine with Allogeneic Stem Cell Transplantation Improves Progression Free Survival in Patients with AML and MDS; Results of a Randomized Phase III Study

Borje S Andersson, MD, PhD, Marcos J de Lima, MD, Rima M Saliba, PhD, Elizabeth J Shpall, MD, Uday Popat, M.D., Roy Jones, MD, PhD, Yago Nieto, MD, PhD, Chitra M Hosing, MD, Partow Kebriaei, MD, Amin M Alousi, MD, Laura L. Worth, MD, PhD, Timothy Madden, Pharm.D., Alison Gulbis, Pharm.D., Julianne J Chen, Gabriela Rondon, MD, Patricia McAdams, RN, Becky McMullin, RN, Michael Andreeff, M.D., Ph.D., Richard Champlin, MD

Blood (2011) 118 (21): 892.

https://doi.org/10.1182/blood.V118.21.892.892

Published: 2011

Journal Articles

Outcomes of High Dose Steroid Treatment with or without Aminocaproic Acid in Critically Ill Stem Cell Transplant Recipients with Diffuse Alveolar Hemorrhage

Nisha Rathi, M.D., Andrew Dinh, BS, Sajid A. Haque, M.D., Lei Feng, Ph.D, Suyu Liu, Wenli Dong, Joseph L Nates, M.D., Kristen J Price, M.D., Uday Popat, M.D.

Blood (2011) 118 (21): 3058.

https://doi.org/10.1182/blood.V118.21.3058.3058

Published: 2011

Journal Articles

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Syed Kazmi, MD, Gary Lu, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Chitra M Hosing, MD, Uday Popat, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4156.

https://doi.org/10.1182/blood.V118.21.4156.4156

Published: 2011

Journal Articles

Predictors of Stem Cell Yield Via Apheresis in Patients Undergoing Stem Cell Mobilization,

Rima M Saliba, Ph.D., Alexandre Chiattone, MD, Alejandro Majlis, MD, Viviane C. Chiattone, RN, Gabriela Rondon, MD, Araci M. Sakashita, MD, Nelson Hamerschlak, MD, Jose Mauro Kutner, MD, PhD, Elizabeth J Shpall, MD, Paolo Anderlini, MD, Issa Khouri, MD, Muzaffar H Qazilbash, MD, Uday Popat, M.D., Richard Champlin, MD, Chitra M Hosing, MD, Marcos De Lima, MD

Blood (2011) 118 (21): 4058.

https://doi.org/10.1182/blood.V118.21.4058.4058

Published: 2011

Journal Articles

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Sairah Ahmed, MD, Heather Lin, PhD, Veera Baladandayuthapani, PhD, Mubeen A Khan, Gary Lu, MD, Gabriela Rondon, MD, Sofia Qureshi, Yvonne T Dinh, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Chitra M Hosing, MD, Uday Popat, M.D., Sergio A Giralt, MD, Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 333.

https://doi.org/10.1182/blood.V118.21.333.333

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: PK Guided IV Busulfan Dose Intensity Results in Improved Event Free Survival

Uday Popat, M.D., Borje S Andersson, MD, PhD, Roland Bassett, Stefan Ciurea, Gabriela Rondon, MD, Amin M Alousi, MD, Paolo Anderlini, MD, Chitra Hosing, MD, Roy Jones, MD, PhD, Partow Kebriaei, MD, Yago Nieto, MD, PhD, Issa Khouri, MD, Elizabeth J Shpall, MD, Srdan Verstovsek, MD, PhD, Muzaffar Qazilbash, MD, Marcos J de Lima, MD, Richard Champlin, MD

Blood (2011) 118 (21): 2006.

https://doi.org/10.1182/blood.V118.21.2006.2006

Published: 2011

Journal Articles

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma,

Shatha Farhan, MD, Heather Lin, PhD, Veerabhadran Baladandayuthapani, Nina Shah, MD, Qaiser Bashir, MD, Chitra M Hosing, MD, Uday Popat, M.D., Simrit Parmar, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4119.

https://doi.org/10.1182/blood.V118.21.4119.4119

Published: 2011

Journal Articles

Determinants of Higher Pre-Apheresis CD34+ Count in Patients Undergoing Autologous Hematopoietic Stem Cell Mobilization

Alexandre Chiattone, MD, Rima M Saliba, PhD, Viviane C. Chiattone, RN, XiaoWen Tang, MD, Nelson Hamerschlak, MD, Farzaneh Maadani, Muzaffar H. Qazilbash, MD, Uday Popat, M.D., Partow Kebriaei, MD, Richard Champlin, MD, Chitra M Hosing, MD, Marcos DeLima, MD

Blood (2011) 118 (21): 4387.

https://doi.org/10.1182/blood.V118.21.4387.4387

Published: 2011

Journal Articles

12-Year Experience with High-Dose Rituximab-Containing Autologous Stem Cell Transplantation for SOX11-Positive Mantle Cell Lymphoma Patients in First Remission: Emerging Lymphoma-Free Survival Plateau After 3 Years,

Zaher I Chakhachiro, MD, Rima M Saliba, Ph.D., Grace-Julia Okoroji, Martin Korbling, MD, Amin M Alousi, MD, Chitra M Hosing, MD, Marcos De Lima, MD, Paolo Anderlini, MD, Uday Popat, M.D., Barry I Samuels, MD, L. Jeffrey Medeiros, MD, Carlos E. Bueso-Ramos, MD, PhD, Richard Champlin, MD, Issa F Khouri, MD

Blood (2011) 118 (21): 4138.

https://doi.org/10.1182/blood.V118.21.4138.4138

Published: 2011

Journal Articles

Long Term Results of Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome: Analysis of Prognostic Factors

Uday Popat, M.D., Roland Bassett, Leandro de Padua Silva, Amin M Alousi, MD, Paolo Anderlini, MD, Chitra M Hosing, MD, Roy Jones, MD, PhD, Partow Kebriaei, MD, Issa Khouri, MD, Elizabeth J Shpall, MD, Muzaffar H Qazilbash, MD, Guillermo Garcia-Manero, Borje S Andersson, MD, PhD, Richard Champlin, MD, Marcos J de Lima, MD

Blood (2011) 118 (21): 4531.

https://doi.org/10.1182/blood.V118.21.4531.4531

Published: 2011

Journal Articles

Pre-Transplant Minimal Residual Disease Detected by Multiparameter Flow Cytometric Analysis Predicts for Disease Relapse in Adult Patients with Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Stem Cell transplantation

Yi Zhou, MD, PhD, Jeffrey L. Jorgensen, MD, PhD, Rima M Saliba, PhD, Sa A. Wang, MD, Gabriela Rondon, MD, Celina Ledesma, B.S., Borje S Andersson, MD, PhD, Marcos J de Lima, MD, Elizabeth J Shpall, MD, Uday Popat, M.D., Stefan O Ciurea, MD, Amin M Alousi, MD, Muzaffar Qazilbash, MD, Chitra M Hosing, MD, L. Jeffrey Medeiros, MD, Richard Champlin, MD, Partow Kebriaei, MD

Blood (2011) 118 (21): 3072.

https://doi.org/10.1182/blood.V118.21.3072.3072

Published: 2011

Journal Articles

Toxicity and Early Response after Intravenous (IV) Busulfan (Bu) Plus Melphalan (Mel) Conditioning for Autologous Stem Cell Transplantation (SCT) in Patients (pts) with Multiple Myeloma (MM).

Partow Kebriaei, MD, Sergio Giralt, MD, Timothy L. Madden, Ph.D., Neil Thapar, Ph.D., Elizabeth J. Shpall, M.D., Chitra Hosing, M.D., Muzaffar H. Qazilbash, M.D., Daniel R. Couriel, M.D., Uday Popat, M.D., Peter F. Thall, Ph.D., Richard E. Champlin, M.D., Roy Jones, M.D./Ph.D., Borje S. Andersson, M.D./Ph.D.

Blood (2006) 108 (11): 2943.

https://doi.org/10.1182/blood.V108.11.2943.2943

Published: 2006

NARROW

Pharmacokinetic Dose Guidance of IV Busulfan with Fludarabine with Allogeneic Stem Cell Transplantation Improves Progression Free Survival in Patients with AML and MDS; Results of a Randomized Phase III Study

Outcomes of High Dose Steroid Treatment with or without Aminocaproic Acid in Critically Ill Stem Cell Transplant Recipients with Diffuse Alveolar Hemorrhage

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Predictors of Stem Cell Yield Via Apheresis in Patients Undergoing Stem Cell Mobilization,

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: PK Guided IV Busulfan Dose Intensity Results in Improved Event Free Survival

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma,

Determinants of Higher Pre-Apheresis CD34+ Count in Patients Undergoing Autologous Hematopoietic Stem Cell Mobilization

12-Year Experience with High-Dose Rituximab-Containing Autologous Stem Cell Transplantation for SOX11-Positive Mantle Cell Lymphoma Patients in First Remission: Emerging Lymphoma-Free Survival Plateau After 3 Years,

Long Term Results of Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome: Analysis of Prognostic Factors

Pre-Transplant Minimal Residual Disease Detected by Multiparameter Flow Cytometric Analysis Predicts for Disease Relapse in Adult Patients with Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Stem Cell transplantation

Toxicity and Early Response after Intravenous (IV) Busulfan (Bu) Plus Melphalan (Mel) Conditioning for Autologous Stem Cell Transplantation (SCT) in Patients (pts) with Multiple Myeloma (MM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only